COMPASS faces IP challenge

New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin

COMPASS Pathways’ (CMPS) patent for crystalline psilocybin is being challenged by the non-profit Freedom to Operate. After conducting advanced analysis, the organization is confident that the formulation isn’t novel and has been known for decades. 

PDF of article